Q-omics provides the consensus-scored PHBP6 profile across patient tissues and cancer cell-line models. PHBP6 expression is associated with patient survival in 8 of 34 cancer types, with the highest sampling consensus in LUAD. Additionally, PHBP6 RNA expression shows 2,440 significant pathway-activity associations, with the highest sampling consensus in ESCA. Together, these results highlight LUAD, and ESCA as cancer lineages where PHBP6 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.